» Articles » PMID: 16610769

HuCNS-SC (StemCells)

Overview
Date 2006 Apr 14
PMID 16610769
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

HuCNS-SC, a proprietary human neural stem cells product, is being developed as a cellular therapy for the potential treatment of Batten disease, one of a group of disorders known as neural ceroid lipofuscinoses (NCL). Developer StemCells is also investigating the therapy for spinal cord injury and other central nervous system disorders, such as demyelinating disease, stroke and Alzheimer's disease. A phase I trial of HuCNS-SC for infantile and late-infantile NCL has been initiated, following the March 2006 U.S. Food and Drug Administration approval of StemCells' investigational new drug application.

Citing Articles

Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.

Sareen D, Gowing G, Sahabian A, Staggenborg K, Paradis R, Avalos P J Comp Neurol. 2014; 522(12):2707-28.

PMID: 24610630 PMC: 4070510. DOI: 10.1002/cne.23578.


Concise review: self-renewal in the central nervous system: neural stem cells from embryo to adult.

De Filippis L, Binda E Stem Cells Transl Med. 2012; 1(4):298-308.

PMID: 23197809 PMC: 3659692. DOI: 10.5966/sctm.2011-0045.


Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model.

Ferrari D, Zalfa C, Nodari L, Gelati M, Carlessi L, Delia D Cell Mol Life Sci. 2011; 69(7):1193-210.

PMID: 22076651 PMC: 11115189. DOI: 10.1007/s00018-011-0873-5.


Neural stem cell transplantation as a therapeutic approach for treating lysosomal storage diseases.

Shihabuddin L, Cheng S Neurotherapeutics. 2011; 8(4):659-67.

PMID: 21904790 PMC: 3250293. DOI: 10.1007/s13311-011-0067-8.


Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis.

Lu J, Hu J, Hofmann S Mol Genet Metab. 2009; 99(4):374-8.

PMID: 20036592 PMC: 2839016. DOI: 10.1016/j.ymgme.2009.12.002.